Three Analyst Firms Start Greenway (GWAY) at Buy, Two at Neutral
Get Alerts GWAY Hot Sheet
Price: $20.35 --0%
Rating Summary:
0 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
0 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
A number of analyst firms have initiated coverage on shares of Greenway Medical Tech (NYSE: GWAY) Tuesday morning:
- Morgan Stanley with an Equalweight rating
- JPMorgan with an Overweight and $19 price target
- Piper Jaffray with a Neutral and $15 target
- William Blair with an Outperform
- Raymond James with an Outperform rating and a $17.50 target
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alliance Laundry principal stockholder prices 22.55M share offering
- Clean Energy Fuels (CLNE) PT Lowered to $2.50 at Raymond James
- KKR prices secondary offering of 5 million BridgeBio shares
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper Jaffray, William Blair, JPMorgan, Raymond James, Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share